# FDA Inspection 1012412 - Akorn, Inc. - March 20, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/akorn-inc/faea5b70-1c3c-4d89-9f2b-ab8462069aeb/
Source feed: FDA_Inspections

> FDA Inspection 1012412 for Akorn, Inc. on March 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012412
- Company Name: Akorn, Inc.
- Inspection Date: 2017-03-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1085157 - 2019-03-05](https://www.globalkeysolutions.net/api/records/fda_inspections/akorn-inc/06d441b4-dfd1-4b39-9cd7-eb33bc7c1996/)
- [FDA Inspection 1004511 - 2017-02-13](https://www.globalkeysolutions.net/api/records/fda_inspections/akorn-inc/fc5c2163-096e-437c-9942-0c8c5fabba59/)
- [FDA Inspection 950673 - 2015-12-18](https://www.globalkeysolutions.net/api/records/fda_inspections/akorn-inc/557800b1-a314-4264-b532-b1fcd52912c4/)
- [FDA Inspection 950673 - 2015-12-18](https://www.globalkeysolutions.net/api/records/fda_inspections/akorn-inc/fbf3f256-7811-4dcc-8f07-3424b0d25ac7/)
- [FDA Inspection 629551 - 2009-11-10](https://www.globalkeysolutions.net/api/records/fda_inspections/akorn-inc/9148056f-03bd-4066-9193-12341fea1825/)

Company: https://www.globalkeysolutions.net/companies/akorn-inc/91871042-8cde-411b-b464-09797e0b23db

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c